Regeneron Pharmaceuticals Inc.
Veloci-Bi - Full-Length Bispecific Antibodies
Veloci-Bi allows for the generation of full-length bispecific antibodies similar to native antibodies that are amenable to production by standard antibody manufacturing techniques and likely to have favorable antibody-like pharmacokinetic properties.